# New Neoplasms clinical trials: 1,414 posted since Nov 2024

Updated November 9, 2026.

1,414 clinical studies in neoplasms were first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026; 236 have an industry sponsor and 1,056 are recruiting or about to. The newest, NCT07926841, was posted on November 9, 2026: Symptom Burden by Level of Therapeutic Intensity in a Palliative Care Unit (Consorci Sanitari de l'Alt Penedès i Garraf).

## The full list

New Neoplasms clinical trials: 1,414 rows for $70.70, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Enrollment, Enrollment type, Location countries, Central contact, Contact phone, Contact email, Last update posted, Read on, Source. The new rows each week by email, about 59 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/condition/neoplasms

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

- New trials: 1,414
- Industry sponsored: 236
- Recruiting or not yet: 1,056
- Latest posted: November 9, 2026

## Newest trials

The newest 100 of 1,414, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Countries | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 9, 2026 | NCT07926841 | Symptom Burden by Level of Therapeutic Intensity in a Palliative Care Unit | Consorci Sanitari de l'Alt Penedès i Garraf | Observational | Not yet recruiting | Neoplasms, Palliative Care | 265 | Spain | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07926841) |
| November 9, 2026 | NCT07925879 | Social Media Perceptions Among Young Adults With Cancer - Aim 1: Interviews | UNC Lineberger Comprehensive Cancer Center | Observational | Completed | Cancer, Cancer Survivors | 33 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07925879) |
| November 9, 2026 | NCT07924384 | Prognostic and Predictive Factors in Childhood Soft Tissue Sarcomas | Institut Curie | Observational | Not yet recruiting | Non-rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) | 150 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07924384) |
| November 9, 2026 | NCT07924241 | Medically Tailored Meals to Improve Cancer Outcomes | Washington University School of Medicine | Not applicable | Not yet recruiting | Cancer, Healthy Eating | 90 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07924241) |
| November 6, 2026 | NCT07923370 | Facial Expression Awareness Training to Understand and Recognize Emotions | Children's Hospital of Philadelphia | Not applicable | Recruiting | Survivors of Pediatric Brain Tumors, Pediatric Cancer | 40 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07923370) |
| November 6, 2026 | NCT07923071 | A Study to Assess the Pharmacokinetics and Safety of Revumenib in Participants With Advanced Cancer and Hepatic or Renal Impairment | Syndax Pharmaceuticals | Phase 1 | Not yet recruiting | Relapsed/Refractory (R/R) Hematologic Malignancies, Acute Leukemia, Refractory Leukemia, Relapsed Leukemia | 18 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07923071) |
| November 6, 2026 | NCT07922902 | Automated Radiation Target Contouring and Treatment Planning Via RATA: A Multi-Center RCT | zhaoxiaohui | Not applicable | Not yet recruiting | Cancer, Malignant Neoplasms, Radiotherapy | 62 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07922902) |
| November 6, 2026 | NCT07921589 | Pilot Testing ACCOMPANI: A Nurse-Targeted Intervention to Promote Psychosocial Equity in Pediatric Oncology | Dana-Farber Cancer Institute | Not applicable | Not yet recruiting | Pediatric Oncology, Childhood Cancers, Psychosocial Circumstances | 80 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07921589) |
| November 6, 2026 | NCT07921576 | Phase 1/2 Study of DS010 in Advanced Cancer Patients With Cachexia | Dartsbio Pharmaceuticals Ltd. | Phase 1/2 | Recruiting | Cancer, Cachexia | 58 | Australia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07921576) |
| November 5, 2026 | NCT07919509 | A Project Assessing the Safety and Feasibility of Using Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Ovarian Cancer During... | University of Alabama at Birmingham | Phase 1 | Not yet recruiting | Cancer, Chemotherapy, Squamous Cell Carcinoma (SCC) | 6 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07919509) |
| November 5, 2026 | NCT07917845 | Evaluation of Massage Therapy for Cancer Related Fatigue in Breast Cancer Survivors | Wake Forest University Health Sciences | Not applicable | Not yet recruiting | Breast Cancer, Fatigue in Cancer Survivors | 34 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07917845) |
| November 4, 2026 | NCT07916636 | Detection Technology of Peripheral Blood ctDNA Based on CRISPR/Cas and Gold Nanoparticles | The First Affiliated Hospital of Zhengzhou University | Observational | Not yet recruiting | Cancer, Circulating Tumor DNA Detection | 100 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07916636) |
| November 4, 2026 | NCT07915271 | Performance of Multi-Cancer Detection Test in Asymptomatic Patients With Neoplastic Lesions | Sun Yat-sen University | Observational | Not yet recruiting | Cancer, Precancerous Lesion, Carcinoma in Situ | 948 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07915271) |
| November 3, 2026 | NCT07913906 | Alberta Cancer Exercise Dose in Colorectal Cancer | University of Calgary | Phase 2 | Not yet recruiting | Cancer, Colorectal Cancer | 90 | Canada | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07913906) |
| November 3, 2026 | NCT07913802 | Prospective Multicenter Cohort Study of Clinical and Molecular Biomarkers in Colorectal Cancer | Vorarlberg Institute for Vascular Investigation and Treatment | Observational | Recruiting | Colorectal Neoplasms | 200 | Austria | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07913802) |
| November 2, 2026 | NCT07911293 | Intratumoral Chlorine Dioxide Injection in Advanced Solid Tumors | SunGlow Innovations LLC | Phase 1 | Not yet recruiting | Solid Tumor, Neoplasms | 50 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07911293) |
| October 30, 2026 | NCT07906301 | Organoid Drug Sensitivity-Guided Therapy for Refractory Tumors | Tianjin Medical University Second Hospital | Not applicable | Recruiting | Refractory Tumors, Organoid | 144 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07906301) |
| October 30, 2026 | NCT07906093 | Expanded Access Program to Provide STC-15 to Patients With Selected Advanced Cancer | STORM Therapeutics LTD | Not applicable | Available | Cancer | Not listed |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07906093) |
| October 29, 2026 | NCT07904247 | CANCER SCREENING PROGRAM ON UNCERTAINTY, ANTİCİPATORY ANXIETY, CANCER AWARENESS, AND E-HEALTH LITERACY IN A STROKE PATIENTS | Ondokuz Mayıs University | Not applicable | Active not recruiting | Cancer, Stroke | 88 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07904247) |
| October 29, 2026 | NCT07903532 | Multicenter Study for External Validation of the TB-NET Score | Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz | Observational | Recruiting | Tumor Burden, Neuroendocrine (NE) Tumors | 400 | Brazil, France, Germany, Italy, Poland, Spain, Sweden, Switzerland, United... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07903532) |
| October 28, 2026 | NCT07901582 | Implementation of a Pain Management Plan in Major Open Abdominal Surgeries. | National and Kapodistrian University of Athens | Not applicable | Recruiting | Abdomen Cancer, Pancreas Adenocarcinoma (MSI-H), Colectomy Left/Right/Total Under Laparotomy, Hepatectomy, Nephrectomy... | 58 | Greece | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07901582) |
| October 27, 2026 | NCT07897110 | AI-generated Treatment Recommendations in Precision Oncology | Charite University, Berlin, Germany | Observational | Recruiting | Cancer | 191 | Germany | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07897110) |
| October 26, 2026 | NCT07895173 | Clinical Outcomes of Stroke in MalIgnanCy | University of L'Aquila | Observational | Not yet recruiting | Stroke, Malignancies Multiple | 1,000 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07895173) |
| October 26, 2026 | NCT07895056 | A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) ABBV-706 in Combination With Tarlatamab and... | AbbVie | Phase 2 | Not yet recruiting | Extensive Stage-Small Cell Lung Cancer | 80 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07895056) |
| October 26, 2026 | NCT07895043 | A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) ABBV-706 in Combination With Alveltamig and... | AbbVie | Phase 2 | Not yet recruiting | Extensive Stage-Small Cell Lung Cancer (ES-SCLC) | 80 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07895043) |
| October 26, 2026 | NCT07894900 | Twenty-five Years of Advanced RadioTherapy at San Raffaele Hospital | IRCCS San Raffaele | Observational | Not yet recruiting | Malignant Tumor, Benign Neoplasm, Parkinson Disease, Trigeminal Neuralgia, Arteriovenous Malformations | 10,000 | Italy | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07894900) |
| October 26, 2026 | NCT07893509 | Outcomes for IR and High Risk (HR) Non-muscle Invasive Bladder Cancer (NMIBC) and ctDNA-based Biomarkers for Response and Recurrence in... | Bladder Cancer Advocacy Network | Observational | Not yet recruiting | NMIBC, MIBC, Muscle Invasive Bladder Cancer (MIBC), Non Muscle Invasive Bladder Cancer | 1,400 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07893509) |
| October 23, 2026 | NCT07891533 | Phase 2 Study of Oral Epetraborole in Adults With Polycythemia Vera | AN2 Therapeutics, Inc | Phase 2 | Not yet recruiting | Polycythemia Vera (SNOMED CT: 109992005) | 75 | Australia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07891533) |
| October 22, 2026 | NCT07890324 | A Phase II Clinical Study Evaluating the Efficacy and Safety of SXRN Injection in Patients With Cancer Cachexia | Jiangsu Guiqiong Pharmaceutical Co., Ltd. | Phase 2 | Not yet recruiting | Cachexia-Anorexia Syndrome, Cachexia; Cancer | 96 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07890324) |
| October 22, 2026 | NCT07888075 | Master Protocol for the Study of Rilogrotug for the Treatment of Weight Loss and Anorexia in Patients With Cancer Cachexia and mCRC or... | AVEO Pharmaceuticals, Inc. | Phase 2/3 | Not yet recruiting | Cachexia; Cancer, Cachexia, Cachexia-Anorexia Syndrome, Metastatic Colorectal Cancer (CRC), Metastatic Non-small Cell... | 950 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07888075) |
| October 21, 2026 | NCT07886853 | Pragmatic Interventions to Advance Cancer Survivor Outcomes | University of Texas Southwestern Medical Center | Observational | Not yet recruiting | Cancer, Malignant Neoplasm | 10,000 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07886853) |
| October 21, 2026 | NCT07886190 | Symptom Monitoring and Management Intervention After CAR-T | Massachusetts General Hospital | Not applicable | Not yet recruiting | Chimeric Antigen Receptor T-cell Therapy, Hematologic Malignancy | 65 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07886190) |
| October 21, 2026 | NCT07885475 | Dexmedetomidine for Refractory Pain in Palliative Cancer Patients | St. Olavs Hospital | Observational | Recruiting | Cancer, Palliative Care, Patient Care, Pain Management, Dexmedetomidine Analgesia, Opioid | 30 | Norway | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07885475) |
| October 20, 2026 | NCT07882329 | Maternal and Fetal Outcomes in Pregnancy With Malignancy | Assiut University | Observational | Not yet recruiting | Pregnancy Disease, Malignancy | 50 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07882329) |
| October 20, 2026 | NCT07882069 | Effect of ACTIVE-Care on Cancer-Related Fatigue, Hope, and Psychological Resilience in Adolescents With Acute Lymphoblastic Leukemia | Selcuk University | Not applicable | Completed | Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma), Adolescent, Resilience... | 70 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07882069) |
| October 19, 2026 | NCT07879547 | Safety and Diagnostic Efficacy of 177Lu-AF03 in Patients With Solid Tumors | Yong He | Early phase 1 | Not yet recruiting | Malignant Solid Tumors, Neoplasms | 8 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07879547) |
| October 16, 2026 | NCT07879469 | Antibody-Drug Conjugate Plus Immunotherapy Versus Immunotherapy Plus Chemotherapy for Extensive Transurethrally Unresectable Very-High-Risk... | Tianjin Medical University Second Hospital | Phase 2 | Not yet recruiting | Bladder (Urothelial, Transitional Cell) Cancer, Antibody-drug Conjugates, Immunotherapy, Chemotherapy, Systemic Therapy | 150 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07879469) |
| October 16, 2026 | NCT07879287 | Internal Jugular Vein and Inferior Vena Cava Collapsibility Indices as a Guidance of Fluid Responsiveness in Septic Shock Cancer Patients | Cairo University | Observational | Completed | Internal Jugular Vein, Inferior Vena Cava, Collapsibility Indices, Fluid Responsiveness, Septic Shock, Cancer | 106 | Egypt | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07879287) |
| October 15, 2026 | NCT07876661 | Effectiveness of a Guided, Web-based, Stepped-care-approach to Cognitive Behavioral Therapy for Insomnia in Cancer Survivors | Vrije Universiteit Brussel | Not applicable | Not yet recruiting | Neoplasms, Cancer Survivorship, Insomnia | 140 | Belgium | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07876661) |
| October 15, 2026 | NCT07876128 | A Clinical Trial of MK-2750 in Participants With Advanced Solid Tumors (MK-2750-002) | Merck Sharp & Dohme LLC | Phase 1/2 | Not yet recruiting | Advanced Solid Tumors, Malignant Neoplasm | 300 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07876128) |
| October 15, 2026 | NCT07874958 | "AFRONTA Emotional Care" Intervention for Family Caregivers of Children With Cancer. | Universidad de Guanajuato | Not applicable | Completed | Caregiver Burden, Child, Cancer | 14 | Mexico | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07874958) |
| October 14, 2026 | NCT07874321 | MRG003 Added to Ongoing Treatment After Progression in EGFR-Positive Advanced Thyroid Cancer | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Phase 2 | Recruiting | Thyroid Cancer, Tumor, Advanced Thyroid Carcinoma | 39 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07874321) |
| October 14, 2026 | NCT07874308 | HR20013 for the Prevention of Nausea and Vomiting in Patients With Cancer: A Real-World Study | Sun Yat-sen University | Observational | Recruiting | Chemotherapy-Induced Nausea and Vomiting (CINV), Nausea, Vomiting, Neoplasms | 3,000 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07874308) |
| October 14, 2026 | NCT07872956 | Feasibility Study of a Co-Designed Gamified Medical Yoga App for Home-Based Cancer Rehabilitation | Linkoeping University | Not applicable | Recruiting | Cancer | 10 | Sweden | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07872956) |
| October 13, 2026 | NCT07871734 | Changes in Anxiety, Depression, Hopelessness, Spirituality, and Distress Levels Before and After Radiotherapy in Cancer Patients | Fatih Goksel | Observational | Completed | Cancer | 389 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07871734) |
| October 13, 2026 | NCT07869836 | BL-M07D1 (Trastuzumab Brengitecan T-bren) vs Standard of Care Platinum-based Chemotherapy (PBC) for HER2-expressing Metastatic Urothelial... | SystImmune Inc. | Phase 3 | Recruiting | Urothelial Cancer, Metastatic Urothelial Cancer, Bladder Cancer, Bladder Cancer (BC), Bladder (Urothelial, Transitional... | 520 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07869836) |
| October 9, 2026 | NCT07869420 | Evaluating Feasibility and Acceptability of Pain Education | University of Oklahoma | Not applicable | Completed | Cognitive Coping, Cancer | 70 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07869420) |
| October 9, 2026 | NCT07868640 | Blood Samples Were Taken From Patients Undergoing Oncological Treatment in Order to Validate the TST79 Molecular Test | Grand Hôpital de Charleroi | Not applicable | Recruiting | Cancer | 15 | Belgium | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07868640) |
| October 8, 2026 | NCT07866534 | Umbilical Cord Blood Infusion to Promote Hematopoietic and Immune Reconstitution in Children With Relapsed or Refractory Malignant Solid... | Tianjin Medical University Cancer Institute and Hospital | Not applicable | Not yet recruiting | Pediatric Cancer, Solid Tumor Cancer | 10 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07866534) |
| October 8, 2026 | NCT07865117 | Development of a Digital Personalised Nutrition Tool for Adolescents Undergoing Cancer Treatment | KU Leuven | Not applicable | Recruiting | Paediatric Oncology, Malnutrition in Children | 30 | Belgium | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07865117) |
| October 8, 2026 | NCT07865013 | AYA Cancer Transitions Program | University of Kansas Medical Center | Not applicable | Not yet recruiting | Cancer, Cancer Survivorship, Adolescent and Young Adult Cancer Survivors, Transitions of Care | 100 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07865013) |
| October 8, 2026 | NCT07864727 | Cardiac Biomarkers in Patients Receiving Immune Checkpoint Inhibitors (PRIME-ICI) | South Tees Hospitals NHS Foundation Trust | Observational | Not yet recruiting | Cardiotoxicity, Cardiac Biomarkers, Cancer | 300 | United Kingdom | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07864727) |
| October 7, 2026 | NCT07864467 | BHF-COLLATE: UK Prospective, Multi-centre, Observational, Cardio-oncology Anthracycline Registry | South Tees Hospitals NHS Foundation Trust | Observational | Not yet recruiting | Cancer and / or Hematological Malignancy, Anthracycline-induced Cardiotoxicity | 200 | United Kingdom | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07864467) |
| October 7, 2026 | NCT07862764 | A Study to Assess Change in Disease State and Adverse Events in Korean Adult Patients With Relapsed or Refractory Diffuse Large B-Cell... | AbbVie | Observational | Not yet recruiting | Diffuse Large B-Cell Lymphoma | 175 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07862764) |
| October 6, 2026 | NCT07861620 | Animal-Assisted Intervention for Children With Cancer and Their Siblings | Azienda Ulss 2 Marca Trevigiana | Not applicable | Completed | Hematologic Neoplasms, Neoplasms | 50 | Italy | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07861620) |
| October 6, 2026 | NCT07861477 | Murottal as Adjunctive Intervention in Pediatric | Universitas Airlangga | Not applicable | Completed | Pediatric Cancer, Hematologic Malignancies, Anxiety, Sleep Disturbances in Children, Leukemia (Both ALL and AML) | 20 | Indonesia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07861477) |
| October 6, 2026 | NCT07861451 | Islamic Spiritual Care Versus Psychological Support in Radiotherapy | Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital | Not applicable | Completed | Cancer | 137 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07861451) |
| October 6, 2026 | NCT07860801 | Study of Vaping Use Among Adolescent and Young Adult Patients With Cancer | Memorial Sloan Kettering Cancer Center | Observational | Enrolling by invitation | Cancer, Vaping | 80 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07860801) |
| October 6, 2026 | NCT07860476 | Impact of Therapeutic Osteopathy-hypnosis on Cancer Patients. | Institut Rafael | Not applicable | Recruiting | Cancer | 80 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07860476) |
| October 6, 2026 | NCT07860372 | Immunonutrition vs EPA-DHA Enriched Nutritional Support in Patients With Cancer Undergoing Surgery | Maimónides Biomedical Research Institute of Córdoba | Observational | Recruiting | Nutrition Aspect of Cancer | 80 | Spain | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07860372) |
| October 6, 2026 | NCT07860359 | Impact of Lung Cancer Screening With Chest Scans Combined With Coaching on Smoking Cessation in Heavy Smokers | Hôpital Fribourgeois | Not applicable | Not yet recruiting | Lung Cancer (Diagnosis), Smoking Cessation, Lung Neoplasm | 116 | Switzerland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07860359) |
| October 6, 2026 | NCT07859592 | Labyrinthin Vaccination in Veterans With Lung Adenocarcinoma | VA Office of Research and Development | Phase 2 | Not yet recruiting | Type and Grade of Toxicities, Demographic and Background Characteristics, Advanced, Metastatic, Recurrent... | 30 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07859592) |
| October 5, 2026 | NCT07858500 | Zolbetuximab and Other Cancer Treatments in People With Advanced Gastric or GEJ Cancer in Clinical Practice (RADIANCE) | Astellas Pharma Europe Ltd. | Observational | Not yet recruiting | Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable... | 1,000 | Canada | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07858500) |
| October 5, 2026 | NCT07857746 | Outcome of HSCT in Children at Ramathibodi Hospital | Mahidol University | Observational | Recruiting | Hematologic Disease and Disorders, Malignancies, Genetic Diseases | 200 | Thailand | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07857746) |
| October 5, 2026 | NCT07857135 | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of SYS6088 in Patients With Advanced/Metastatic Solid Tumors | CSPC Megalith Biopharmaceutical Co.,Ltd. | Phase 1/2 | Not yet recruiting | Advanced/Metastatic Solid Tumors | 140 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07857135) |
| October 5, 2026 | NCT07856914 | Paricalcitol Versus Pirfenidone for Improving Surgical Resectability in Patients With Peritoneal Cancer | Patrick Wagner, MD, FACS | Phase 2 | Not yet recruiting | Peritoneal (Metastatic) Cancer, Peritoneal Carcinoma, Peritoneal Carcinosis, Peritoneal Cancer, Peritoneal... | 74 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07856914) |
| October 5, 2026 | NCT07856745 | Efficacy and Safety of FLEXIPORT Implantable Port in Chemotherapeutic Treatments | Portal Access Ltd. | Not applicable | Completed | Neoplasms | 40 | Dominican Republic | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07856745) |
| October 2, 2026 | NCT07856394 | Adding Spatially Fractionated Radiation Therapy to Standard Palliative Radiation for Improving Disease-Related Symptoms in Patients With... | Mayo Clinic | Not applicable | Recruiting | Metastatic Malignant Solid Neoplasm, Unresectable Malignant Solid Neoplasm, Unresectable Solid Tumor, Malignant Tumor... | 100 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07856394) |
| October 2, 2026 | NCT07855666 | Safety and Efficacy of Ultrasound-Guided Percutaneous Nephrostomy in Oncology Patients | Assiut University | Not applicable | Not yet recruiting | Obstructive Uropathy, Hydronephrosis, Ureteral Obstruction, Acute Kidney Injury, Neoplasms | 40 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07855666) |
| October 2, 2026 | NCT07855484 | Improving Goals of Care Conversations Between Doctors and Young Adults With Cancer | Memorial Sloan Kettering Cancer Center | Not applicable | Enrolling by invitation | Cancer | 118 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07855484) |
| October 1, 2026 | NCT07853209 | A Phase 3 Study of \[177Lu\]Ludotadipep for Metastatic Castration-Resistant Prostate Cancer | FutureChem | Phase 3 | Recruiting | Prostate Cancer, mCRPC | 114 | South Korea | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07853209) |
| October 1, 2026 | NCT07852858 | Supporting Families In Coping With Parental Cancer: A Multi-Site Randomized Controlled Trial | M.D. Anderson Cancer Center | Not applicable | Not yet recruiting | Cancer | 400 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07852858) |
| October 1, 2026 | NCT07852468 | Cancer Pain 101: A Digital, Asynchronous Intervention of Pain Management in Advanced Cancer | University of Alabama at Birmingham | Not applicable | Not yet recruiting | Cancer, Pain, Advanced Cancer | 45 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07852468) |
| October 1, 2026 | NCT07852013 | Eye-Tracking Alcohol Warning | University of Miami | Not applicable | Not yet recruiting | Alcohol | 50 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07852013) |
| September 30, 2026 | NCT07850700 | Ambient AI Documentation in Oncology Consultations | National Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos | Observational | Not yet recruiting | Neoplasms, Clinical Documentation, Artificial Intelligence in Medicine | 250 | Lithuania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07850700) |
| September 30, 2026 | NCT07850453 | Vortosiran for VTE Prevention | Ribocure Pharmaceuticals AB | Phase 2 | Not yet recruiting | Venous Thromboembolism (VTE), Cancer, Pulmonary Embolism (Diagnosis) | 150 | Bulgaria, France, Poland, Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07850453) |
| September 30, 2026 | NCT07849699 | Implementing Stepped Financial and Legal Navigation to Mitigate Financial Toxicity in Adolescent and Young Adult Cancer Patients Oncology... | University of Louisville | Not applicable | Not yet recruiting | Financial Toxicity, Cancer, Adolescent, Young Adult Cancer Survivors | 294 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07849699) |
| September 30, 2026 | NCT07848906 | Alcohol and Cancer Message Testing Experiment | University of Connecticut | Not applicable | Not yet recruiting | Alcohol, Message Perception, PME | 1,400 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07848906) |
| September 30, 2026 | NCT07848841 | Online Perioperative Education Program on Patient Satisfaction and Clinical Outcomes for Head and Neck Surgery | Washington University School of Medicine | Not applicable | Recruiting | Head and Neck Cancer (H&N), Cancer of the Head and Neck | 50 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07848841) |
| September 29, 2026 | NCT07846800 | The LifeMeds Cohort | Tilburg University | Observational | Not yet recruiting | Multimorbidity, Cancer, Cardio Vascular Disease, Chronic Respiratory Conditions, Type 2 Diabetes | 2,000 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07846800) |
| September 29, 2026 | NCT07845903 | A Prospective Study to Observe Clinical Outcomes in Patients Receiving Antiplatelet or Anticoagulant Therapy for Cancer-Associated Acute... | Xuanwu Hospital, Beijing | Observational | Not yet recruiting | Acute Ischemic Stroke, Cancer | 60 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07845903) |
| September 28, 2026 | NCT07845422 | A Study of Music Therapy for Anxiety in People With Cancer | Memorial Sloan Kettering Cancer Center | Not applicable | Recruiting | Cancer | 240 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07845422) |
| September 28, 2026 | NCT07843433 | ImprovINg the TIMEly Diagnosis and Treatment of Cancer and Cardio-metabolic Diseases in People With Mental Disorders: Reducing Health... | IRCCS San Raffaele | Observational | Not yet recruiting | Mental Health, Cancer, Cardiometabolic Diseases | 120 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07843433) |
| September 24, 2026 | NCT07838168 | Integration of Palliative Care in Pediatric Onco-hematology | Nantes University Hospital | Observational | Not yet recruiting | Pediatric Cancer, Palliative Care | 45 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07838168) |
| September 24, 2026 | NCT07838090 | Resistance Training and Creatine Supplementation for Head and Neck Cancer | Medical University of South Carolina | Not applicable | Not yet recruiting | Head and Neck Cancer, Cancer Survivorship, Treatment-related Muscle Loss, Physical Function | 30 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07838090) |
| September 23, 2026 | NCT07837440 | Psychoeducation for Anxiety, Depression, Cognitive Avoidance, and Sense of Coherence in Women With Cancer | Ardakan University | Not applicable | Completed | Cancer | 40 | Iran | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07837440) |
| September 23, 2026 | NCT07837063 | Monitoring Treatment Response With Urine and Serum Metabolome Markers in Patients Treated With Novel Hormone Therapy and Have Either... | The Clatterbridge Cancer Centre NHS Foundation Trust | Observational | Not yet recruiting | Cancer, Urology | 40 | United Kingdom | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07837063) |
| September 22, 2026 | NCT07834021 | Body Scan Meditations to Support Well-Being in Patients at Antwerp University Hospital. | Universiteit Antwerpen | Not applicable | Completed | Well-being | 29 | Belgium | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07834021) |
| September 22, 2026 | NCT07833982 | Efficacy of an Integrated Psychological Interventions Combined With Ar\_Rahman Listening for Reducing Psychological Distress and Enhancing... | Shaheed Zulfikar Ali Bhutto Institute of Science and Technology (SZABIST) University | Not applicable | Not yet recruiting | Psychological Distress (Depression, Anxiety and Stress) Cancer | 60 | Pakistan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07833982) |
| September 22, 2026 | NCT07832630 | Saruparib in HRDsig+ Solid Tumors | Abramson Cancer Center at Penn Medicine | Phase 2 | Not yet recruiting | Malignant Neoplastic Disease (Disorder) | 124 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07832630) |
| September 21, 2026 | NCT07831148 | Music Therapy Program for Patients in Palliative Care (MUSPAL360) | Austral University, Argentina | Not applicable | Not yet recruiting | Cancer, Palliative Care | 40 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07831148) |
| September 21, 2026 | NCT07830368 | Evaluating the Implementation of a Need-Based Cancer Survivorship Program | The University of Hong Kong | Not applicable | Recruiting | Cancer Survivorship | 12,500 | Hong Kong | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07830368) |
| September 21, 2026 | NCT07829757 | A Study of Zolbetuximab Given With mFOLFOX6 or CAPOX Chemotherapy in Indian Adults With Gastric Cancer | Astellas Pharma Global Development, Inc. | Phase 4 | Not yet recruiting | Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable... | 50 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07829757) |
| September 18, 2026 | NCT07829276 | Study on the Efficacy and Safety of Different Doses of PEG-rhG-CSF for Primary Prevention of Febrile Neutropenia | Zhejiang Provincial People's Hospital | Observational | Enrolling by invitation | Malignant Tumor | 350 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07829276) |
| September 18, 2026 | NCT07829146 | Feasibility Pilot of AYA-PARTNER | UNC Lineberger Comprehensive Cancer Center | Not applicable | Not yet recruiting | Cancer, Malignancies Multiple | 30 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07829146) |
| September 18, 2026 | NCT07828288 | Beyond Psychological Distress: Implementation of a Dyadic Behavioral Intervention Targeting Neuroendocrine and mRNA Translational Pathways... | Ponce Medical School Foundation, Inc. | Phase 1 | Not yet recruiting | CASA Intervention, Usual Care | 114 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07828288) |
| September 18, 2026 | NCT07828028 | The Effect of the 4-7-8 Breathing Technique on Anxiety, Symptom Burden, and Sleep Quality During Chemotherapy | Malatya Turgut Ozal University | Not applicable | Completed | Chemotherapy | 64 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07828028) |
| September 18, 2026 | NCT07827378 | Early Discharge After Colorectal Surgery | Fundación para la Investigación del Hospital Clínico de Valencia | Observational | Not yet recruiting | Cancer, Colo-rectal Cancer | 97 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07827378) |
| September 18, 2026 | NCT07827066 | Multi-Theory Model-Based AI Agent Intervention for Smoking Cessation in Early-Stage Cancer Patients | Sun Yat-sen University | Not applicable | Not yet recruiting | Smoking Cessation, Early-Stage Cancer, AI Agent | 156 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07827066) |
| September 17, 2026 | NCT07825090 | Association of ICU Admission Time, Age Stratification, and Clinical Frailty Scale With 30-Day Mortality in Geriatric Oncology Patients | Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital | Observational | Active not recruiting | Cancer, Frailty, Mortality | 150 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07825090) |

## Sponsors posting most

| Sponsor | New trials | Latest |
| --- | --- | --- |
| M.D. Anderson Cancer Center | 17 | October 1, 2026 |
| AbbVie | 16 | October 26, 2026 |
| Merck Sharp & Dohme LLC | 16 | October 15, 2026 |
| Assistance Publique - Hôpitaux de Paris | 14 | July 31, 2026 |
| UNC Lineberger Comprehensive Cancer Center | 13 | November 9, 2026 |
| Wake Forest University Health Sciences | 11 | November 5, 2026 |
| Memorial Sloan Kettering Cancer Center | 11 | October 6, 2026 |
| University of Alabama at Birmingham | 10 | November 5, 2026 |
| Hospices Civils de Lyon | 10 | April 14, 2026 |
| Washington University School of Medicine | 9 | November 9, 2026 |
| The Hong Kong Polytechnic University | 9 | August 24, 2026 |
| Dana-Farber Cancer Institute | 8 | November 6, 2026 |
| Sun Yat-sen University | 8 | November 4, 2026 |
| The University of Hong Kong | 8 | September 21, 2026 |
| National Cancer Institute (NCI) | 8 | July 21, 2026 |
| Medical University of South Carolina | 7 | September 24, 2026 |
| Stanford University | 7 | August 28, 2026 |
| AstraZeneca | 7 | June 15, 2026 |
| University of Salamanca | 7 | June 10, 2026 |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | 7 | March 17, 2026 |

## By phase

| Phase | New trials | Latest |
| --- | --- | --- |
| [Not applicable](https://specstream.ai/data/clinical-trials/phase/not-applicable) | 617 | November 9, 2026 |
| [Observational](https://specstream.ai/data/clinical-trials/phase/observational) | 410 | November 9, 2026 |
| [Phase 1](https://specstream.ai/data/clinical-trials/phase/phase-1) | 117 | November 6, 2026 |
| [Phase 2](https://specstream.ai/data/clinical-trials/phase/phase-2) | 111 | November 3, 2026 |
| [Phase 1/2](https://specstream.ai/data/clinical-trials/phase/phase-1-2) | 59 | November 6, 2026 |
| [Phase 3](https://specstream.ai/data/clinical-trials/phase/phase-3) | 44 | October 13, 2026 |
| [Early phase 1](https://specstream.ai/data/clinical-trials/phase/early-phase-1) | 25 | October 19, 2026 |
| [Phase 2/3](https://specstream.ai/data/clinical-trials/phase/phase-2-3) | 19 | October 22, 2026 |
| [Phase 4](https://specstream.ai/data/clinical-trials/phase/phase-4) | 12 | September 21, 2026 |

## By country

| Country | New trials | Latest |
| --- | --- | --- |
| [United States](https://specstream.ai/data/clinical-trials/country/united-states) | 427 | November 9, 2026 |
| [China](https://specstream.ai/data/clinical-trials/country/china) | 192 | November 6, 2026 |
| [France](https://specstream.ai/data/clinical-trials/country/france) | 122 | November 9, 2026 |
| [Turkey (Türkiye)](https://specstream.ai/data/clinical-trials/country/turkey-t-rkiye) | 90 | October 29, 2026 |
| [Spain](https://specstream.ai/data/clinical-trials/country/spain) | 80 | November 9, 2026 |
| [Italy](https://specstream.ai/data/clinical-trials/country/italy) | 77 | October 29, 2026 |
| [United Kingdom](https://specstream.ai/data/clinical-trials/country/united-kingdom) | 70 | October 8, 2026 |
| [Canada](https://specstream.ai/data/clinical-trials/country/canada) | 61 | November 3, 2026 |
| [Australia](https://specstream.ai/data/clinical-trials/country/australia) | 46 | November 6, 2026 |
| [South Korea](https://specstream.ai/data/clinical-trials/country/south-korea) | 41 | October 1, 2026 |
| [Taiwan](https://specstream.ai/data/clinical-trials/country/taiwan) | 40 | September 8, 2026 |
| [Germany](https://specstream.ai/data/clinical-trials/country/germany) | 37 | October 29, 2026 |
| [Japan](https://specstream.ai/data/clinical-trials/country/japan) | 35 | September 15, 2026 |
| [Netherlands](https://specstream.ai/data/clinical-trials/country/netherlands) | 35 | July 27, 2026 |
| [Belgium](https://specstream.ai/data/clinical-trials/country/belgium) | 34 | October 15, 2026 |
| [Denmark](https://specstream.ai/data/clinical-trials/country/denmark) | 33 | July 9, 2026 |
| [Switzerland](https://specstream.ai/data/clinical-trials/country/switzerland) | 29 | October 29, 2026 |
| [Brazil](https://specstream.ai/data/clinical-trials/country/brazil) | 26 | October 29, 2026 |
| [Israel](https://specstream.ai/data/clinical-trials/country/israel) | 24 | August 18, 2026 |
| [Poland](https://specstream.ai/data/clinical-trials/country/poland) | 23 | October 29, 2026 |
| [Egypt](https://specstream.ai/data/clinical-trials/country/egypt) | 21 | October 16, 2026 |
| [Sweden](https://specstream.ai/data/clinical-trials/country/sweden) | 19 | October 29, 2026 |
| [Greece](https://specstream.ai/data/clinical-trials/country/greece) | 16 | October 28, 2026 |
| [Hong Kong](https://specstream.ai/data/clinical-trials/country/hong-kong) | 16 | September 21, 2026 |
| [Romania](https://specstream.ai/data/clinical-trials/country/romania) | 13 | September 30, 2026 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it.

Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).